 | Up a level |
Grove, Jane I; Stephens, Camilla; Lucena, M Isabel; Andrade, Raúl J; Weber, Sabine; Gerbes, Alexander; Bjornsson, Einar S; Stirnimann, Guido; Daly, Ann K; Hackl, Matthias; Khamina-Kotisch, Kseniya; Marin, Jose J G; Monte, Maria J; Paciga, Sara A; Lingaya, Melanie; Forootan, Shiva S; Goldring, Christopher E P; Poetz, Oliver; Lombaard, Rudolf; Stege, Alexandra; ... (2023). Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study. Diagnostic and prognostic research, 7(1), p. 18. BioMed Central 10.1186/s41512-023-00155-z
Ravindra, Kodihalli C; Vaidya, Vishal S; Wang, Zhenyu; Federspiel, Joel D; Virgen-Slane, Richard; Everley, Robert A; Grove, Jane I; Stephens, Camilla; Ocana, Mireia F; Robles-Díaz, Mercedes; Isabel Lucena, M; Andrade, Raul J; Atallah, Edmond; Gerbes, Alexander L; Weber, Sabine; Cortez-Pinto, Helena; Fowell, Andrew J; Hussaini, Hyder; Bjornsson, Einar S; Patel, Janisha; ... (2023). Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans. Nature communications, 14(1), p. 1215. Nature Publishing Group 10.1038/s41467-023-36858-6
